Med-techs face critical business and regulatory challenges in Asia Pacific
17-Oct-17, Clarivate Analytics
The medical device industry is facing an accelerated pace of change on multiple fronts – technological advancements, reimbursement questions and regulatory change. In the Asia-Pacific region these challenges are becoming more prominent.
%20Pharma%20Intelligence.jpg "Med techs face critical business and regulatory challenges in Asia Pacific (c) Pharma Intelligence")
Image: Pharma Intelligence
The market size for medical devices in the Asia-Pacific region is estimated to reach USD88 billion by the end of 2020 and is expected to be the world’s second largest med-tech market after the US.
The projected growth is driven by various trends: an aging population, the rise of non-communicable diseases, an increase of public healthcare spending, an emerging middle class, a dynamic reform landscape and an untapped market potential.